Skip to content Skip to footer
U.S. Daily Cases pass 70,000 while the debate was basically a draw

U.S. Daily Cases pass 70,000 while the debate was basically a draw – 23rd October

Dr. Anthony Fauci the director of the U.S. National Institute of Allergy and Infectious Diseases declared that the U.S. was in a precarious place as daily cases exceeded 70,000 for the first time since late July.

The debate last night between President Donald Trump and former Vice-President Joe Biden was markedly more civil than the last debate.  The candidates did manage to score a few points on each other but the general consensus was that not many minds were changed by the end of it all.

Markets in the U.S. were again mainly flat to end the week ranging from the Dow slipping by 0.10%, while the NASDAQ gained 0.37%.

Intel drops on earnings and analyst downgrade

Shares of Intel fell by over 10% as Bank of America downgraded the stock from Neutral to Underperform.

The tech bellwether’s stock fell by $5.70  to $48.20 a share as the company’s data center revenue fell by 7% and the Q3 earnings report was roundly disappointing.  Analysts commented that there is no easy fix for the business and the next generation of Intel chips will be delayed.

Vaccine trials resume in the U.S.

AstraZeneca resume its recently paused Covid-19 vaccine trial.  The company had stopped the trial on September 6th after a report of neurological illness in a participant in U.K. 

On Friday U.S. regulators approved the restart of the U.S. based trial, while an independent safety panel recommended that Johnson & Johnson resume its large scale trial that was halted last week after a participant had fallen ill.

AstraZeneca’s shares were up 0.08% to $52 at the close, while J&J increased by 0.11% to $145.24per share.

Quote of the day –  “When it’s raining gold, reach for a bucket, not a thimble.”

Warren Buffet

To stay up to date with the markets we encourage traders to view our Trade Gate Hub for more real time insights into Crude, Gold and many other markets.

Tradeview Ltd. is not a portfolio manager or an investment advisor. This Market Report is for informational purposes only. Any statements made or opinions voiced in this Market Report do not constitute investment advice. The Tradeview Ltd. Market Report does not constitute a solicitation to buy or sell in the financial markets. Although the information contained in the Market Report comes from trusted sources, Tradeview Ltd. is not responsible for guaranteeing the accuracy, timeliness, completeness, or fitness of such sources. Tradeview Ltd. shall not be responsible for and disclaims all liability for any losses which may be suffered from access and use of the contents of the Tradeview Ltd. Market Report. Trading any financial instrument on margin, using leverage or otherwise involves considerable risk. Therefore, before deciding to participate in any style of trading, you should carefully consider your investment objectives, level of experience and risk appetite. Most importantly, do not invest money you cannot afford to lose. Consulting with your investment counselor, attorney, accountant or other professional upon whom you rely for guidance as to the appropriateness of an investment in any style of trading is recommended.

Tradeview Ltd.

Is licensed to carry on securities investment business and is regulated by the Cayman Islands Monetary Authority (CIMA) as a full securities broker-dealer. Tradeview conducts business pursuant to the Cayman Islands Securities Investment Business Law (SIBL) and its activities fall under the direct supervision of the Investments and Securities Division of CIMA.
Headquarters: 5th Floor Anderson Square, 64 Shedden Road, Georgetown, Grand Cayman, Cayman Islands KY1-1002, BWI.

Tradeview Asia Ltd.

Is licensed and regulated by the Labuan Financial Services Authority (FSA) as a Money Broker, registration number LL15870 licensed to facilitate transactions in foreign exchange pursuant to Labuan Financial Services and Securities Act 2010, the Labuan Companies Act 1990 and the Labuan Business Activity Tax Act 1990.
Headquarters: International Business Financial Centre at Office 5, Jamie Business Center I, Unit F10, First Floor, Paragon Labuan, Jalan Mustapha, 87000 Labuan F.T.

Tradeview Europe Ltd.

Is licensed as a Category 2 Investment Service Company and is regulated by the Malta Financial Services Authority (MFSA). The Malta Financial Services Authority (MFSA) is the single regulator for financial services in Malta. MFSA is a fully autonomous public institution and reports to Parliament on an annual basis. The MFSA is a member of the European Banking Authority (EBA), the European Securities and Markets Authority (ESMA) and the International Organization of Securities Commissions (IOSCO) and is a signatory of the Multilateral Memorandum of Understanding with other European regulatory Institutions. Tradeview is authorized to provide financial services across multiple asset classes and is passported in the EU/EEA under MiFID II (EU Markets in Financial Instruments Directive).
Headquarters: 157 Archbishops Street, Valletta VLT Malta 1440.

Tradeview Financial Markets S.A.C Global

Is authorized to conduct business pursuant to and in compliance with the General Law of Companies (LGS) promulgated by the government of Peru. Tradeview Financial Markets S.A.C is registered with the National Superintendence of Public Registries (SUNARP), company number 13089531. Tradeview Financial Markets S.A.C provides financial services in selected OTC derivative markets in compliance with all applicable government regulations.
Headquarters: Los Mirtos 239 Urb. San Eugenio, Lince, Lima, Perú.